A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Clinical trial NCT01714713 · COMPLETED

Trial details

NCT number: NCT01714713
Sponsor: FORUM Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Impaired Cognition

Start date: 2013-06-01
Primary completion: 2015-10-01
Enrollment: 830

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.